Morgan Stanley downgraded UBS (UBS) to Equal Weight from Overweight with a price target of CHF 34, down from CHF 35. The company’s integration momentum was strong in Q4, and should continue in 2025, the analyst tells investors in a research note. The firm maintains a positive view on UBS’s earnings profile, but says the stock’s risk/reward skew now looks more balanced ahead of the key Swiss authorities decision on capital in May.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UBS:
- UBS Group AG: Navigating Capital Uncertainty with a Hold Rating Amid Robust Earnings Outlook
- Goldman Sachs (GS) Lifts Price Target on Gold as Rally Continues
- JPM, MS: Global Banks Face Fines in South Korea for Short-Selling Violations
- EV Battery Giant CATL Seeks Hong Kong Listing as U.S. Tariffs Tighten
- Analysts Shower Coca-Cola (KO) with Buy Ratings Post Q4 Results